Study Stopped
The Data Safety Monitoring Board determined that the serious adverse event rate was higher among patients awaiting enrollment in the home-based primary care intervention compared to those who had initiated home-based primary care.
Home-based Primary Care for Homebound Seniors
2 other identifiers
interventional
230
1 country
1
Brief Summary
The objective of this pragmatic randomized controlled trial is to compare the impact of physician directed home-based primary care with office-based primary care on hospitalizations, symptom control, caregiver burden, healthcare costs and other outcomes for older homebound adults and to conduct a dissemination and implementation evaluation to support future home-based primary care adoption
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2016
CompletedFirst Posted
Study publicly available on registry
November 16, 2016
CompletedStudy Start
First participant enrolled
February 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2020
CompletedOctober 19, 2020
October 1, 2020
3.4 years
November 14, 2016
October 14, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of Hospitalization
at 12 months
Incidence of ED visits
at 12 months
Study Arms (2)
Home-based Primary Care Arm
EXPERIMENTALParticipants in this arm will be assigned a Mount Sinai Visiting Doctors primary care physician who makes a home based primary care visit.
Usual Care Arm
ACTIVE COMPARATORParticipants in this arm will receive the usual care at office based visits
Interventions
Care in the programs is inter-professional and team-based. Each physician leads a team charged with the care of a panel of patients and directs the team's activities. New patients are assigned a Mount Sinai Visiting Doctors (MSVD) primary care physician or the Chelsea Village House Calls Program (CVHCP) who makes an initial visit within 2 weeks of the patient's enrollment in the program. The primary care physician completes a comprehensive medical history and physical exam during the initial visit including standardized assessments of physical functioning and cognition. The primary care physician then provides ongoing management of the patients' acute and chronic health problems, including palliative and home hospice care when needed, every 2 to 12 weeks as determined on a case-by-case basis.
Eligibility Criteria
You may qualify if:
- Age ≥65 years with Medicare
- Able to provide informed consent (patient or proxy)
- Permanently requires assistance in ≥2 activities of daily living
- Patient or proxy reports that patient is home-bound (leaves the home infrequently for non-medical purposes or cannot leave the home without assistance)
- ≥1 hospitalization in past 12 months
- Speaks English or Spanish
- Willingness to accept a home-based primary care physician as their primary care physician.
You may not qualify if:
- Patients must live in Manhattan, have access to a telephone 24 hours a day, 7 days a week, not be on hemodialysis, agree to open the door and allow access to the members of the team
- If there is any active drug use/sale or firearms in home, we exclude for safety reasons
- A 2-week prognosis will be based on the opinion of the patient's primary care provider or by consensus among physicians on the research team
- Patients in hospice at baseline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinailead
- National Institutes of Health (NIH)collaborator
- National Institute on Aging (NIA)collaborator
- NYU Langone Healthcollaborator
- University of California, San Franciscocollaborator
- Visiting Nurse Service of New Yorkcollaborator
- The New Jewish Homecollaborator
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Alex Federman, MD, MPH
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Geriatrics and Palliative Medicine
Study Record Dates
First Submitted
November 14, 2016
First Posted
November 16, 2016
Study Start
February 8, 2017
Primary Completion
July 10, 2020
Study Completion
July 10, 2020
Last Updated
October 19, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share